End of this week we could get an approval or more delays. No guarantee SP will move on an approval as the sales part of this company are rather slow on the uptake so an approval is no given for increased sales. Great medical application, it works and has DVA approvals so is it worth the risk and buying more on a slow uptake? Think I will wait and if approved and SP remains flat will buy more otherwise bye bye bargain.
- Forums
- ASX - By Stock
- AVH
- Ann: AVITA Medical to Announce First Quarter 2024 Results
Ann: AVITA Medical to Announce First Quarter 2024 Results, page-146
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.53 |
Change
0.030(0.86%) |
Mkt cap ! $246.6M |
Open | High | Low | Value | Volume |
$3.62 | $3.64 | $3.46 | $1.133M | 322.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5285 | $3.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.60 | 1212 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 3.500 |
1 | 5000 | 3.490 |
2 | 14347 | 3.450 |
1 | 281 | 3.440 |
2 | 9963 | 3.420 |
Price($) | Vol. | No. |
---|---|---|
3.600 | 1212 | 2 |
3.640 | 2747 | 1 |
3.650 | 1500 | 1 |
3.690 | 552 | 1 |
3.700 | 7031 | 4 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online